Protein C News and Research

RSS

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

30 Aug 2022

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers assessed the impact of SARS-CoV-2 ORF-6 on innate immune signaling.

30 Aug 2022

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

Researchers performed a structural bioinformatics analysis to evaluate the binding energy of the SARS-CoV-2 Omicron variants of concern spike protein receptor-binding domain to human angiotensin-converting enzyme 2 receptor compared to other VOCs.

30 Aug 2022

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers used culture and molecular assays to provide the first dose-response for SARS-CoV-2 solution exposed to UV222.

30 Aug 2022

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

30 Aug 2022

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

A new study explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

Study reveals a 'stealing' mechanism that contributes to antibody diversity

A few years ago, Professor Kathrin de la Rosa and her colleagues in the lab of the Swiss immunologist Antonio Lanzavecchia made an unusual discovery.

29 Aug 2022

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

A study conducted by researchers in Brazil, Australia, Austria and the United States has made significant discoveries about a type of pediatric cancer with no approved drugs for treatment and with a low survival rate.

29 Aug 2022

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

29 Aug 2022

Inhaling silica nanoparticles can damage the kidneys

Amorphous silica is a common mineral used in the manufacturing of products ranging from toothpaste to semiconductors.

29 Aug 2022

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

An international consortium of researchers has identified genetic variants in 10 genes that elevate a person's susceptibility to Crohn's disease, a form of inflammatory bowel disease.

29 Aug 2022

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Inside a living cell, proteins and other molecules are often tightly packed together. These dense clusters can be difficult to image because the fluorescent labels used to make them visible can't wedge themselves in between the molecules.

29 Aug 2022

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

In a new story, scientists explored human herpesvirus-6 (HHV-6) and Epstein–Barr virus (EBV) reactivation among acute coronavirus disease 2019 (COVID-19) patients.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

The W.M. Keck Foundation has awarded a $1.2 million grant to medicinal chemistry and computational biology researchers at the University of Kansas and the University of Chicago focused on addressing a long-unresolved problem in biomedical research - finding molecules able to target the "undruggable proteome."

29 Aug 2022

Protein C News and Research

Study reveals impacts of multiple SARS-CoV-2 Wuhan-based vaccinations on the Omicron variant of concern

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Study reveals a 'stealing' mechanism that contributes to antibody diversity

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Inhaling silica nanoparticles can damage the kidneys

Researchers identify multiple genes and rare variants linked with Crohn's disease susceptibility

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Researchers receive $1.2 million Keck Foundation grant to find molecules for targeting the 'undruggable proteome'

Inactivation of particular protein complex associated with Parkinson's and anxiety disorders

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Preliminary study shows tecovirimat was well tolerated by patients with monkeypox

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News